Mechanism of activation of a human oncogene
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The oncogene of the human EJ bladder carcinoma cell lines arose via alteration of a cellular proto-oncogene. Experiments are presented that localize the genetic lesion that led to activation of the oncogene. The lesion has no affect on levels of expression of the oncogene. Instead, it affects the structure of the oncogene-encoded protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [76]
Citations
Cites
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
A new method for sequencing DNA.
Maxam, A. M., & Gilbert, W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.560 · Cited by 7,922
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
McCann, J., Choi, E., Yamasaki, E., & Ames, B. N. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5135 · Cited by 3,323
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Spragg, S. P. (1979) · Nature · doi:10.1038/278085a0 · Cited by 1,707
Transformation of mammalian cells with genes from procaryotes and eucaryotes
Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., & Axel, R. (1979) · Cell · doi:10.1016/0092-8674(79)90093-x · Cited by 1,408
DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.
Manley, J. L., Fire, A., Cano, A., Sharp, P. A., & Gefter, M. L. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3855 · Cited by 1,211
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citation
Research works printed but not linked: 1
- Ellis, R. W., DeFeo, D., Furth, M. E. & Scolnick, E. M. Cell (in the press).
Cited by
Items 501–600 of 1,000
Sarkar, S., Kacinski, B. M., Kohorn, E. I., Merino, M. J., Carter, D., & Blakemore, K. J. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90677-0 · Cited by 40
Myeloid Cell Transformation by ras-Containing Murine Sarcoma Viruses
Pierce, J. H., & Aaronson, S. A. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.4.667 · Cited by 40
Structural effects of substitutions on the p21 proteins.
Pincus, M. R., & Brandt‐Rauf, P. W. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3596 · Cited by 40
Ras inhibition enhances autophagy, which partially protects cells from death
Schmukler, E., Grinboim, E., Schokoroy, S., Amir, A., Wolfson, E., Kloog, Y., & Pinkas-Kramarski, R. (2013) · Oncotarget · doi:10.18632/oncotarget.703 · Cited by 38
Forty years of cancer modelling in the mouse
Hirst, G. L., & Balmain, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.013 · Cited by 43
Control of expression of the human glutathione S-transferase π gene differs from its rat orthologue
DIXON, K. H., Cowell, I. G., Xia, C., Pemble, S. E., KETTERER, B., & Taylor, J. B. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92295-x · Cited by 39
Warnakulasuriya, S., Chang, S. E., & Johnson, N. W. (1992) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1992.tb00106.x · Cited by 39
Taylor, J., Garrett, D. S., & Wang, M. J. (1988) · Biopolymers · doi:10.1002/bip.360271004 · Cited by 39
Honkawa, H., Masahashi, W., Hashimoto, S., & Hashimoto-Gotoh, T. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2933-2940.1987 · Cited by 39
Inhibited Intercellular Communication as a Mechanistic Link Between Teratogenesis and Carcinogenesis
Loch-Caruso, R. K., Trosko, J. E., & Larsen, W. J. (1985) · Critical Reviews in Toxicology · doi:10.3109/10408448509056269 · Cited by 39
Inhibition of DNA methyltransferases in vitro by benzo[a]pyrene diol epoxide-modified substrates.
Wojciechowski, M., & Meehan, T. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42758-x · Cited by 38
Barrett, J. C., Oshimura, M., Tanaka, N., & Tsutsui, T. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2127-9_36 · Cited by 38
Latent Viruses and Mutated Oncogenes: No Evidence for Pathogenicity
DUESBERG, P. H., & Schwarz, J. R. (1992) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)61047-8 · Cited by 38
Detection of a molecular complex between ras proteins and transferrin receptor
Finkel, T., & Cooper, G. M. (1984) · Cell · doi:10.1016/0092-8674(84)90062-x · Cited by 38
Delannoy, P., Pelczar, H., Vandamme, V., & Verbert, A. (1993) · Glycoconjugate Journal · doi:10.1007/bf00731192 · Cited by 38
Therapeutic Efficacy of an Adenovirus-Mediated Anti-H- ras Ribozyme in Experimental Bladder Cancer
Irie, A., Anderegg, B., Kashani–Sabet, M., OHKAWA, T., SUZUKI, T., Halks‐Miller, M., Curiel, D., & Kj, S. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.341 · Cited by 38
Molecular genetics of human bladder carcinomas
Perucca-Lostanlen, D., Szepetowski, P., Simon, M., & Gaudray, P. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90136-x · Cited by 38
Historical retrospective of the SRC oncogene and new perspectives (Review)
Simatou, A., Simatos, G., Goulielmaki, M., Spandidos, D. A., Baliou, S., & Zoumpourlis, V. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2091 · Cited by 44
Benitah, S. A., & Lacal, J. C. (2001) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(01)67029-6 · Cited by 39
Ammit, A. J., Kane, S. A., & Panettieri, R. A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.6.3731 · Cited by 37
Messenger RNA in regenerating liver: implications for the understanding of regulated growth
Fausto, N. (1984) · Molecular and Cellular Biochemistry · doi:10.1007/bf00231309 · Cited by 37
Borowy‐Borowski, H., & Chambers, R. W. (1987) · Biochemistry · doi:10.1021/bi00383a010 · Cited by 37
Probable physical mechanisms of the activation of oncogenes through carcinogens
Ladik, J. J., & Čížek, J. (1984) · International Journal of Quantum Chemistry · doi:10.1002/qua.560260530 · Cited by 37
Drugging the Undruggable Ras — Immunotherapy to the Rescue?
June, C. H. (2016) · New England Journal of Medicine · doi:10.1056/nejme1612215 · Cited by 37
Genome-guided discovery of cancer therapeutic targets
Konda, P., Garinet, S., Allen, E. M. V., & Viswanathan, S. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112978 · Cited by 36
The human c-abl oncogene in the philadelphia translocation
Groffen, J., Stephenson, J. R., Heisterkamp, N., Bartram, C. R., de Klein, A., & Grosveld, G. C. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210421 · Cited by 36
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging
Sugano, K., & Kakizoe, T. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0649 · Cited by 36
Suzuki, K. (1997) · Journal of Radiation Research · doi:10.1269/jrr.38.55 · Cited by 36
Vandamme, V., Cazlaris, H. E., Marer, N. L., Laudet, V., Lagrou, C., Verbert, A., & Delannoy, P. (1992) · Biochimie · doi:10.1016/0300-9084(92)90188-k · Cited by 38
Malone, P. R., Visvanathan, K., Ponder, B. A. J., Shearer, R. J., & Summerhayes, I. C. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb07028.x · Cited by 36
Trangle, S. S., Juster, D., Kloog, Y., & Pinkas‐Kramarski, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075269 · Cited by 40
Computational Approaches to Prioritize Cancer Driver Missense Mutations
Zhao, F., Zheng, L., Goncearenco, A., Panchenko, A. R., & Li, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072113 · Cited by 35
Rentschler, M., Braumüller, H., Briquez, P. S., & Wieder, T. (2022) · Cancers · doi:10.3390/cancers14061364 · Cited by 38
Warburg and Krebs and related effects in cancer
Unterlass, J. E., & Curtin, N. J. (2019) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2019.4 · Cited by 37
Saltarelli, D., FISCHER, S., & Gâcon, G. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(85)80161-3 · Cited by 35
RAS GENES AND ACUTE MYELOID LEUKAEMIA
Toksoz, D., Farr, C. J., & Marshall, C. J. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb06265.x · Cited by 35
Greenhalgh, D. A., Welty, D. J., Strickland, J. E., & Yuspa, S. H. (1989) · Molecular Carcinogenesis · doi:10.1002/mc.2940020406 · Cited by 35
The induction and control of radiogenic transformation in vitro: Cellular and molecular mechanisms
Borek, C. G. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90066-x · Cited by 36
Gessler, M., & Barnekow, A. (1984) · Bioscience Reports · doi:10.1007/bf01128817 · Cited by 35
The Non-Coding Oncogene: A Case of Missing DNA Evidence?
Shahrouki, P., & Larsson, E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00170 · Cited by 34
The Emerging Molecular Landscape of Urothelial Carcinoma
Solomon, J. P., & Hansel, D. E. (2016) · Surgical pathology clinics · doi:10.1016/j.path.2016.04.004 · Cited by 34
Castro, P., Soares, P., Gusmão, L., Seruca, R., & Sobrinho-Simões, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209491 · Cited by 34
Somatic Mutation in Peripheral Lymphocytes of Former Workers at the Okunojima Poison Gas Factory
Yanagida, J., Hozawa, S., Ishioka, S., Maeda, H., Takahashi, K., Oyama, T., Takaishi, M., Hakoda, M., Akiyama, M., & Yamakido, M. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01556.x · Cited by 34
Amplification of c-yes-1 proto-oncogene in a primary human gastric cancer.
Seki, T., FUJII, G., Mori, S., Tamaoki, N., & Shibuya, M. (1985) · PubMed · Cited by 34
Oncogenes: Implications for the Diagnosis and Treatment of Cancer
Cline, M. J., SLAMON, D. J., & Lipsick, J. S. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-2-223 · Cited by 34
Robinson, A. P., Williams, A. R. W., Piris, J., Spandidos, D. A., & Wyllie, A. H. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.256 · Cited by 34
Han, K., & Kulesz-Martin, M. F. (1992) · PubMed · Cited by 34
Squamous metaplasia of normal and carcinoma in situ of HPV 16-immortalized human endocervical cells.
Sun, Q., Tsutsumi, K., Kelleher, M. B., Pater, A., & Pater, M. M. (1992) · PubMed · Cited by 34
Clark, L., Edington, K. G., Swan, I., McLay, K., Newlands, W. J., Wills, L., Young, H. A., Johnston, P., Mitchell, R. T., & Robertson, G. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.396 · Cited by 34
Bell, J. C., Jardine, K. E., & McBurney, M. W. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.2.617 · Cited by 37
Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme
Funato, T., Shitara, T., Tone, T., Jiao, L., Kashani‐Sabet, M., & Scanlon, K. J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90572-x · Cited by 34
Tarpley, W. G., Hopkins, N. K., & Gorman, R. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3703 · Cited by 34
Garrett, C. T. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90176-2 · Cited by 34
A look at the possible mechanism and potential of magneto therapy
Jacobson, J. I. (1991) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(05)80074-8 · Cited by 33
Chakraborty, A. K., Cichutek, K., & DUESBERG, P. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2217 · Cited by 33
The study of mammalian organogenesis by mosaic pattern analysis
Iannaccone, P. M. (1987) · Cell Differentiation · doi:10.1016/0045-6039(87)90415-5 · Cited by 33
Ruiz‐Rubio, M., Hera, C., & Pueyo, C. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01989.x · Cited by 33
c-Ha-ras-1 oncogene lies between beta-globin and insulin loci on human chromosome 11p.
Fearon, E. R., Antonarakis, S. E., Meyers, D. A., & Levine, M. A. (1984) · Europe PMC (PubMed Central) · Cited by 33
Analysis of viral and somatic activations of the cHa-ras gene
Tabin, C. J., & Weinberg, R. A. (1985) · Journal of Virology · doi:10.1128/jvi.53.1.260-265.1985 · Cited by 33
Self-citationLacal, J. C., Anderson, P. S., & Aaronson, S. A. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04267.x · Cited by 33
Pater, A., & Pater, M. M. (1986) · Journal of Virology · doi:10.1128/jvi.58.2.680-683.1986 · Cited by 33
Kozak, C. A., Strauss, P. G., & Tsichlis, P. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.4.894-897.1985 · Cited by 33
Ramel, C. (1986) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(86)90025-4 · Cited by 33
Sasaki, K., Umeda, M., Sakai, A., Yamazaki, S., & Tanaka, N. (2015) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2014.967058 · Cited by 32
RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins
Çetin, M. S., Evenson, W. E., Gross, G. G., Jalali‐Yazdi, F., Krieger, D., Arnold, D. B., Takahashi, T. T., & Roberts, R. W. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.008 · Cited by 32
Evaluation of malignant lymphomas using three classifications and the working formulation
LIEBERMAN, P. H., Filippa, D. A., Straus, D. J., Thaler, H. T., Cirrincione, C., & Clarkson, B. D. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90285-8 · Cited by 32
Molecular Cloning and Characterization of an Activated Human c-raf-1 Gene
Fukui, M., Yamamoto, T. S., Kawai, S., Mitsunobu, F., & Toyoshima, K. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1776 · Cited by 32
Inhibitors of the ras oncogene as therapeutic targets
Ghobrial, I. M., & Adjei, A. A. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00050-3 · Cited by 35
Development of transformed phenotype induced by a human ras oncogene is inhibited by interferon
Samid, D., Chang, E. H., & Friedman, R. M. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90635-7 · Cited by 32
Self-citationModulation of the expression of the rabbit galectin-3 gene by p53 and c-Ha-ras proteins and PMA
Gaudin, J., Arar, C., Monsigny, M. L. P., & Legrand, A. (1997) · Glycobiology · doi:10.1093/glycob/7.8.1089 · Cited by 32
Polyamines induce malignant transformation in cultured NIH 3T3 fibroblasts
Tabib, A., & Bachrach, U. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00073-3 · Cited by 32
Stevens, C. W., Manoharan, T. H., & Fahl, W. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.3875 · Cited by 32
Nozari, G., Rahbar, S., & Wallace, R. B. (1986) · Gene · doi:10.1016/0378-1119(86)90004-1 · Cited by 32
The human c-Ha-ras2 is a processed pseudogene inactivated by numerous base substitutions
Miyoshi, J., Kagimoto, M., Soeda, E., & Sakaki, Y. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.4.1821 · Cited by 32
Monoclonal antibody specific for an activated RAS protein.
Carney, W. P., Petit, D. J., HAMER, P. J., Der, C. J., Finkel, T., Cooper, G. M., Lefebvre, M., Mobtaker, H., DeLellis, R. A., & Tischler, A. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7485 · Cited by 32
An unusual conformation of NAD+ bound to sorbitoldehydrogenase?
Gronenborn, A. M., Clore, G. M., & Jeffery, J. (1984) · Journal of Molecular Biology · doi:10.1016/s0022-2836(84)80023-6 · Cited by 32
Enrique, P. (1985) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(85)90201-8 · Cited by 31
Cancer genes, proto-oncogenes, and development
OHLSSON, R. I., & Pfeifer‐Ohlsson, S. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90327-2 · Cited by 35
Oncogenes: cause or consequence in the development of glial tumors
Akbaşak, A., & Akbaşak, B. S. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90060-x · Cited by 31
Activation of Ha- ras p21 by Substitution, Deletion, and Insertion Mutations
Chipperfield, R. G., Jones, S. S., Lo, K.-M., & Weinberg, R. A. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1809 · Cited by 31
Self-citationInhibition of SHP2 as an approach to block RAS-driven cancers
Chou, Y., & Bivona, T. G. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.002 · Cited by 33
ras Activation in Human Tumors and in Animal Model Systems
Corominas, M., Sloan, S. R., León, J., Kamino, H., Newcomb, E. W., & Pellicer, À. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.919319 · Cited by 37
Kumagai, M., Makioka, A., Takeuchi, T., & Nozaki, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311478200 · Cited by 30
Relationship between Ras pathways and cell cycle control
Ewen, M. E. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_1 · Cited by 37
Sakaguchi, A. Y., Lalley, P. A., & Naylor, S. L. (1983) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01539146 · Cited by 30
Willecke, K., & Sch�fer, R. (1984) · Human Genetics · doi:10.1007/bf00286587 · Cited by 30
Mimura, C. S., Admon, A., Hurt, K. A., & Ames, G. F.-L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45405-6 · Cited by 30
Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer
López‐Cortés, A., Paz‐y‐Miño, C., Guerrero, S. X., Jaramillo-Koupermann, G., Cáceres, Á. L., Intriago-Baldeón, D. P., García-Cárdenas, J. M., Guevara‐Ramírez, P., Armendáriz‐Castillo, I., Leone, P., et al. (2019) · The Pharmacogenomics Journal · doi:10.1038/s41397-019-0102-4 · Cited by 32
Galectin‐3 mRNA level depends on transformation phenotype in ras‐transformed NIH 3T3 cells
Hebert, E., & Monsigny, M. L. P. (1994) · Biology of the Cell · doi:10.1016/0248-4900(94)90057-4 · Cited by 29
Oncogenes and the molecular biology of cancer.
Weinberg, R. A. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.6.1661 · Cited by 29
Self-citationEssigmann, J. M., & Wood, M. L. (1993) · Toxicology Letters · doi:10.1016/0378-4274(93)90044-x · Cited by 29
Shirahata, S., Rawson, C., Loo, D. T., Chang, Y., & Barnes, D. W. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041440110 · Cited by 29
Expression and Characterization of ras mRNAs from Saccharomyces cerevisiae
Temeles, G. L., Defeo-Jones, D., Tatchell, K., Ellinger, M. S., & Scolnick, E. M. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2298-2305.1984 · Cited by 29
Self-citationLacal, J. C., & Aaronson, S. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5400 · Cited by 29
Localization of the mcf.2 transforming sequence to the X chromosome.
Noguchi, T., Mattéi, M., Oberlé, I., Planche, J., Imbert, J., Pelassy, C., Birg, F., & Birnbaum, D. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02368.x · Cited by 29
The discovery of cellular oncogenes.
Morange, M. (1993) · PubMed · Cited by 29
Needleman, S. W., Yuasa, Y., Srivastava, S. K., & Aaronson, S. A. (1983) · Science · doi:10.1126/science.6623066 · Cited by 29
Corell, B., & Zoll, B. (1988) · Human Genetics · doi:10.1007/bf00366247 · Cited by 29
Lack of correlation between rare Ha‐ras alleles and urothelial cancer in Japan
Ishikawa, J., Maeda, S., Takahashi, R., Kamidono, S., & Sugiyama, T. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400407 · Cited by 29
Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
Umstead, M., Xiong, J., Qi, Q., Du, Y., & Fu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.15049 · Cited by 29
Metadata
- Authors
- Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Nature
- Published
- 1982-11
- Volume
- 300
- Issue
- 5888
- Pages
- 143-149
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2013973825
- Cited by
- 1,393
- References
- 43
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 14 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 23 · 2015: 17 · 2014: 10 · 2013: 20 · 2012: 18
- FWCI
- 97.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Keywords
- oncogene activation, proto-oncogenes, bladder cancer, EJ cell line
- MeSH terms
- Proto-Oncogene Mas, Base Sequence, Urinary Bladder Neoplasms, Cell Line, Cell Transformation, Neoplastic, Cloning, Molecular, DNA Restriction Enzymes, Gene Expression Regulation, Humans, Molecular Weight, Mutation, Neoplasm Proteins, Oncogenes, RNA, Neoplasm, Transfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.